Provided by Tiger Fintech (Singapore) Pte. Ltd.

Altimmune, Inc.

5.62
+0.16002.93%
Post-market: 5.650.0300+0.53%19:59 EDT
Volume:3.88M
Turnover:22.01M
Market Cap:455.82M
PE:-4.50
High:5.81
Open:5.48
Low:5.47
Close:5.46
Loading ...
Mar 27, 2020

Major Issues Report

8-K - Current report
Mar 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 01, 2019

Major Issues Report

Current report, items 5.02, 5.07, and 9.01
Aug 21, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Aug 19, 2019

Correspondence

[Cover]Correspondence
Aug 14, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 13, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 15, 2019

Major Issues Report

Current report, items 2.01, 3.02, 7.01, and 9.01
Jul 09, 2019

Major Issues Report

Current report, items 1.01, 3.02, 7.01, and 9.01
Jun 21, 2019

Major Issues Report

Current report, item 5.02
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Major Issues Report

Current report, items 5.02 and 9.01